CURRENT SERIES:
Prostate Cancer

Episode 11 - Personalized Medicine in CRPC

During this segment, the panelists review the use of personalized medicine in castration-resistant prostate cancer.
During this segment, the panelists explore the use of personalized medicine in castration-resistant prostate cancer.

Jeffrey D. Dunn, PharmD, MBA, and Raoul S. Concepcion, MD, explain that clinicians hope to have better data available in the future to provide definitive answers about treatment options for specific patient populations.

Dr Concepcion explains the variables that are being reviewed to help clinicians make wiser treatment decisions for their patients.

 


However, E. David Crawford, MD, reminds the panelists why achieving this goal will not be easy.



 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up